Acutaas Chemicals to host investor meet at PL Capital conference on Sep 28

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Acutaas Chemicals to attend PL Capital Mid & Small Cap Conference on September 28, 2026
  • Meetings scheduled for one-on-one and group interactions in Mumbai
  • Company confirms no unpublished price-sensitive information will be shared
  • Disclosure made under SEBI Listing Regulations to BSE and NSE
powered bylight_fuzz_icon
51612363

*this image is generated using AI for illustrative purposes only.

Acutaas Chemicals will interact with investors and analysts at the PL Capital Mid & Small Cap Conference 2026 in Mumbai on September 28, 2026. The company officials will attend one-on-one and group meetings during the event.

The interaction is scheduled as part of the conference titled Emerging Titans: Unlocking India's Next Growth Leaders. Acutaas Chemicals stated that no unpublished price-sensitive information will be discussed during these sessions.

Event details

The company filed an intimation with the BSE and NSE regarding the schedule of the investor meet. The event will take place in Bandra Kurla Complex, Mumbai.

Date Conference Interaction Type Location
September 28, 2026 PL Capital Mid & Small Cap Conference 2026 One on One / Group Meetings BKC, Mumbai

The schedule is subject to change, as noted by the company. This disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Acutaas Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-5.20%-4.03%+2.47%+35.32%+122.71%+436.63%

How might Acutaas Chemicals' participation in the 'Emerging Titans' conference influence institutional investor sentiment and stock liquidity in the mid-cap segment?

What specific growth metrics or capacity expansion updates are analysts likely to seek from management during these one-on-one meetings?

Could this high-profile investor engagement signal a potential upcoming capital raise or strategic partnership announcement for the company?

Acutaas Chemicals granted process patent for 2,4-dimethylthiophenol

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Patent granted for 2,4-dimethylthiophenol preparation process
  • Total patents held by company now stand at 11
  • Patent term is 20 years from filing date in 2017
  • Disclosure made under SEBI LODR Regulation 30
powered bylight_fuzz_icon
50591016

*this image is generated using AI for illustrative purposes only.

Acutaas Chemicals received a process patent from the Indian Patent Office on September 10, 2026. The approval covers a method for preparing 2,4-dimethylthiophenol, developed at the company’s internal R&D centre.

The patent is valid for 20 years from the filing date of September 21, 2017. This grant raises Acutaas Chemicals’ total portfolio to 11 patents for innovative processes and technology.

The company disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was issued to both the BSE and NSE listing departments.

What the Numbers Show

The accumulation of 11 patents indicates a sustained focus on indigenous process innovation. With the latest patent covering a specific chemical preparation method, the company reinforces its technical moat in specialty chemicals.

Historical Stock Returns for Acutaas Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-5.20%-4.03%+2.47%+35.32%+122.71%+436.63%

How will the commercialization of the 2,4-dimethylthiophenol process impact Acutaas Chemicals' revenue streams in the upcoming fiscal quarters?

Does this new patent provide a significant competitive advantage against global specialty chemical manufacturers, and if so, in which specific end-use industries?

What is the estimated timeline for scaling up production of 2,4-dimethylthiophenol from R&D to full-scale manufacturing?

More News on Acutaas Chemicals

1 Year Returns:+122.71%